← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2012Last known activity
Oct 30, 2024
Timeline
1940s
- Mar 1, 1941
IlDong Pharmaceutical Co Ltd— Founded
Drugs by trial phase (42 distinct, 49 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (17 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Alzheimer Disease
- Dyslipidemias
- Dyspepsia
- Erectile Dysfunction
- Esophageal Diseases
- Essential Hypertension
- Fatty Liver
- Gastroesophageal Reflux
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Hypertension
- Hypothyroidism
- Migraine Disorders
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Prostatic Hyperplasia
- Renal Insufficiency
Recent trials (49)
- NCT06635226Lead sponsorPhase 1Oct 30, 2024
- NCT06063291Lead sponsorPhase 1Nov 15, 2023
- NCT05663879Lead sponsorPhase 1Dec 7, 2022
- NCT05604287Lead sponsorPhase 1Oct 10, 2022
- NCT05259020Lead sponsorPhase 1Feb 22, 2022
- NCT05202912Lead sponsorPhase 1Jan 16, 2022
- NCT04982705Lead sponsorPhase 1Jul 7, 2021
- NCT04725994Lead sponsorPhase 1Jun 28, 2021
- NCT04218162Lead sponsorPhase 3Mar 1, 2020
- NCT04185090Lead sponsorPhase 1Feb 29, 2020
- NCT04249908Lead sponsorPhase 1Feb 13, 2020
- NCT04174716Lead sponsorPhase 1/Phase 2Nov 6, 2019
- NCT03937648Lead sponsorPhase 1Aug 1, 2019
- NCT04202536Lead sponsorPhase 4May 29, 2019
- NCT03907228Lead sponsorN/AMar 15, 2019
Details
- Founded
- Seoul, KR Mar 1, 1941
- Last known activity
- Oct 30, 2024